THOMAS KEFALAS: Open Payments
NPI 1255625869 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 24 payments from 17 companies in 2025. Trend: 2023 $97 · 2024 $311 · 2025 $704
Food & beverage: $605Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $123 |
| Ipsen Biopharmaceuticals, Inc | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Lilly USA, LLC | 2 | $45 |
| ARRAY BIOPHARMA INC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| TerSera Therapeutics LLC | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: LIBTAYO, OPDIVO, Nubeqa, Zoladex, ICLUSIG, ENHERTU, Vyloy, LYNOZYFIC.
Industry payments across NC — which companies pay providers there.
